Neurological Complications in Children

Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 150)

References

  1. 1.
    Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91:1382–1390.PubMedCrossRefGoogle Scholar
  2. 2.
    Ibrahim K, Appleton R. Seizures as the presenting symptom of brain tumours in children. Seizure. 2004;13:108–112.PubMedCrossRefGoogle Scholar
  3. 3.
    Khajavi K, Comair YG, Wyllie E, et al. Surgical management of pediatric tumor-associated epilepsy. J Child Neurol. 1999;14:15–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Khan RB, Boop FA, Onar A, et al. Seizures in children with low grade tumors: outcome after tumor resection and risk factors for uncontrolled seizures. J Neurosurg. 2006;104:377–382.PubMedGoogle Scholar
  5. 5.
    van Breemen MS, Vecht CJ. Optimal seizure management in brain tumor patients. Curr Neurol Neurosci Rep. 2005;5:207–213.PubMedCrossRefGoogle Scholar
  6. 6.
    Hildebrand J, Lecaille C, Perennes J, et al. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65:212–215.PubMedCrossRefGoogle Scholar
  7. 7.
    Giulioni M, Gardella E, Rubboli G, et al. Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J Clin Neurosci. 2006;13:529–535.PubMedCrossRefGoogle Scholar
  8. 8.
    Vecht CJ, van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology. 2006;67:S10–S13.PubMedGoogle Scholar
  9. 9.
    Khan RB, Onar A. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia. 2006;47:375–379.PubMedCrossRefGoogle Scholar
  10. 10.
    Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke. 1995;26:131–136.PubMedCrossRefGoogle Scholar
  11. 11.
    Brant-Zawadzki M, Anderson M, DeArmond SJ, et al. Radiation-induced large intracranial vessel occlusive vasculopathy. AJR Am J Roentgenol. 1980;134:51–55.PubMedGoogle Scholar
  12. 12.
    Nishimoto A, Takeuchi S. Moyamoya disease. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam, Netherlands: North Holland; 1972;12:352–383.Google Scholar
  13. 13.
    Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68:932–938.PubMedCrossRefGoogle Scholar
  14. 14.
    Horn P, Pfister S, Bueltmann E, et al. Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst. 2004;20:382–391.PubMedCrossRefGoogle Scholar
  15. 15.
    Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–935.PubMedCrossRefGoogle Scholar
  16. 16.
    Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:5277–5282.PubMedCrossRefGoogle Scholar
  17. 17.
    Sciubba DM, Gallia GL, Recinos P, et al. Intracranial aneurysm following radiation therapy during childhood for a brain tumor. Case report and review of the literature. J Neurosurg. 2006;105:134–139.PubMedGoogle Scholar
  18. 18.
    Burn S, Gunny R, Phipps K, et al. Incidence of cavernoma development in children after radiotherapy for brain tumors. J Neurosurg.2007;106:379–383.PubMedGoogle Scholar
  19. 19.
    Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32:871–876.PubMedGoogle Scholar
  20. 20.
    Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol. 2000;18:824–831.PubMedGoogle Scholar
  21. 21.
    Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin N Am. 2003;21:167–192.Google Scholar
  22. 22.
    Childhood Brain Tumor Consortium:The epidemiology of headache among children with brain tumor. J Neurooncol. 1991;10:31–46.Google Scholar
  23. 23.
    Wilne SH, Ferris RC, Nathwani A, et al. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child. 2006;91:502–506.PubMedCrossRefGoogle Scholar
  24. 24.
    Kaur A, Selwa L, Fromes G, et al. Persistent headache after supratentorial craniotomy. Neurosurgery. 2000;47:633–636.PubMedGoogle Scholar
  25. 25.
    de Gray LC, Matta BF. Acute and chronic pain following craniotomy: a review. Anaesthesia. 2005;60:693–704.PubMedCrossRefGoogle Scholar
  26. 26.
    Purdy RA, Kirby S. Headaches and brain tumors. Neurol Clin. 2004;22:39–53.PubMedCrossRefGoogle Scholar
  27. 27.
    Partap S, Walker M, Longstreth WT Jr, et al. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 2006;66:1105–1107.PubMedCrossRefGoogle Scholar
  28. 28.
    Pruitt A, Dalmau J, Detre J, et al. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology. 2006;67:676–678.PubMedCrossRefGoogle Scholar
  29. 29.
    Lewis D, Ashwal S, Hershey A, et al. (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–2224.PubMedGoogle Scholar
  30. 30.
    Hershey AD, Powers SW, Bentti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000; 40:539–549.PubMedCrossRefGoogle Scholar
  31. 31.
    Damen L, Bruijn J, Koes BW, et al. Prophylactic treatment of migraine in children. Part 1. A systematic review of non-pharmacological trials. Cephalalgia. 2006;26:373–383.PubMedCrossRefGoogle Scholar
  32. 32.
    Lövblad K, Kelkar P, Ozdoba C, et al. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol. 1998;28:86–91.PubMedCrossRefGoogle Scholar
  33. 33.
    Riva D, Giorgi C, Nichelli F, et al. Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology. 2002;59:48–53.PubMedGoogle Scholar
  34. 34.
    Kishi T, Tanaka Y, Ueda K. Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer. 2000;89:925–931.PubMedCrossRefGoogle Scholar
  35. 35.
    Matsumoto S, Nishizawa S, Murakami M, et al. Carmofur-induced leukoencephalopathy: MRI. Neuroradiology. 1995;37:649–652.PubMedCrossRefGoogle Scholar
  36. 36.
    Wen PY, Schiff D, Kesari S, et al. Medical management of patients with brain tumors. J Neurooncol. 2006;80:313–332.PubMedCrossRefGoogle Scholar
  37. 37.
    Rosen GM, Bendel AE, Neglia JP, et al. Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics. 2003;112:e46–e54.PubMedCrossRefGoogle Scholar
  38. 38.
    Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol. 2003;16:677–683.PubMedCrossRefGoogle Scholar
  39. 39.
    Fearnley JM, Stevens JM, Rudge P. Superficial siderosis of the central nervous system. Brain. 1995;118:1051–1066.PubMedCrossRefGoogle Scholar
  40. 40.
    McCarron MO, Flynn PA, Owens C, et al. Superficial siderosis of the central nervous system many years after neurosurgical procedures. J Neurol Neurosurg Psychiatry. 2003;74:1326–1328.PubMedCrossRefGoogle Scholar
  41. 41.
    Koeppen AH, Dickson AC, Chu RC, et al. The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol1993;34:646–653.PubMedCrossRefGoogle Scholar
  42. 42.
    Anderson NE, Sheffield S, Hope JK. Superficial siderosis of the central nervous system: a late complication of cerebellar tumors. Neurology. 1999;52:163–169.PubMedGoogle Scholar
  43. 43.
    Pace A, Bove L, Nistico C, et al. Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients. J Neurol Neurosurg Psychiatry.1996;61:409–411.PubMedCrossRefGoogle Scholar
  44. 44.
    Topp KS, Tanner KD, Levine JD. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol. 2000;424:563–576.PubMedCrossRefGoogle Scholar
  45. 45.
    Nozaki-Taguchi N, Chaplan SR, Higuera ES, et al. Vincristine-induced allodynia in the rat. Pain. 2001;93:69–76.PubMedCrossRefGoogle Scholar
  46. 46.
    Posner JB. Neurologic Complications of Cancer. Philadelphia: FA Davis; 1995.Google Scholar
  47. 47.
    London Z, Albers JW. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin. 2007;25:257–276.PubMedCrossRefGoogle Scholar
  48. 48.
    Antunes NL. Acute neurologic complications in children with systemic cancer. J Child Neurol.2000;15:705–16.PubMedCrossRefGoogle Scholar
  49. 49.
    Reddy AT, Witek K. Neurologic complications of chemotherapy for children with cancer. Curr Neurol Neurosci Rep.2003;3:137–42.PubMedCrossRefGoogle Scholar
  50. 50.
    Albers J, Chaudhry V, Cavaletti G, Donehower R. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev.2007;24:CD005228.Google Scholar
  51. 51.
    Hausheer FH, Schilsky RL, Bain S. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol.2006;33:15–49.PubMedCrossRefGoogle Scholar
  52. 52.
    Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy. Neurology.2005;64:26–31.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of NeurologyStanford University, Stanford Comprehensive Cancer CenterStanfordUSA
  2. 2.Stanford UniversityPalo AltoUSA
  3. 3.Departments of Neurology, Pediatrics, Neurosurgery, and Human BiologyStanford University Medical CenterPalo AltoUSA

Personalised recommendations